GNMX
Aevi Genomic Medicine, Inc.
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
73 hedge funds and large institutions have $19.2M invested in Aevi Genomic Medicine, Inc. in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 9 closing their positions.
Holders
73
Holders Change
-3
Holders Change %
-3.95%
% of All Funds
1.82%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
21
Reduced
21
Closed
9
Calls
$2.74M
Puts
$549K
Net Calls
+$2.19M
Net Calls Change
-$4.06M
Top Buyers
| 1 |
1
BlackRock
New York
|
$3.75M |
| 2 |
BBA
2
Baker Bros. Advisors
New York
|
$3.01M |
| 3 |
3
Goldman Sachs
New York
|
$396K |
| 4 |
2L
4
22NW LP
Seattle,
Washington
|
$288K |
| 5 |
RFCA
5
R&F Capital Advisors
New York
|
$157K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CS
76
Credit Suisse
Zurich,
Switzerland
| – | – | -13,578 | Closed |
|
|
TRCT
77
Tower Research Capital (TRC)
New York
| – | – | -3,870 | Closed |
|
78
Citigroup
New York
| $0 | 39 | -1,065 | -96% |
|
79
Simplex Trading
Chicago,
Illinois
| $0 | 300 | -408 | -58% |
|
80
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | – | -200 | Closed |
|
|
WVP
81
Worth Venture Partners
Fort Lee,
New Jersey
| – | – | – | – |
|
82
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
83
Parallax Volatility Advisers
San Francisco,
California
| – | – | – | – |
|
|
DAM
84
DLD Asset Management
New York
| – | – | – | – |
|
|
CG
85
Cutler Group
San Francisco,
California
| $0 | 28 | +28 | New |
|
86
Barclays
London,
United Kingdom
| $0 | 310 | +227 | +273% |
|